BeatingCancerCenter - The Di Bella Method

Title	Created Date
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor	25 February 2014
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland	25 February 2014
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells	20 February 2014
New concepts in prolactin biology	20 February 2014
Somatostatin in breast cancer	19 February 2014
Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells	19 February 2014
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]	19 February 2014
Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma	12 February 2014
Molecular mechanisms of somatostatin receptor trafficking	10 February 2014
Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis	10 February 2014

Display #

Page 163 of 171

Latest